Chief Investment Officer of Scientia Capital, a specialized global investment fund focused exclusively on life sciences.
Prior to this, Lawrence was responsible for the largest biotechnology investment portfolio in Australia as the institutional biotechnology analyst at Queensland Investment Corporation, an investment fund managing over AU$60 billion.
